Cornerstone Wealth Group LLC Buys 867 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Cornerstone Wealth Group LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.9% in the second quarter, according to the company in its most recent filing with the SEC. The firm owned 11,831 shares of the healthcare conglomerate’s stock after acquiring an additional 867 shares during the quarter. Cornerstone Wealth Group LLC’s holdings in UnitedHealth Group were worth $6,025,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of UnitedHealth Group by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after acquiring an additional 544,740 shares during the period. Price T Rowe Associates Inc. MD boosted its holdings in shares of UnitedHealth Group by 0.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares in the last quarter. Capital Research Global Investors raised its holdings in shares of UnitedHealth Group by 2.2% during the 4th quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after buying an additional 324,733 shares in the last quarter. Capital International Investors boosted its stake in UnitedHealth Group by 4.8% in the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after buying an additional 542,424 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at $5,802,231,000. Institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Stock Up 1.0 %

Shares of NYSE UNH traded up $5.79 during trading on Friday, hitting $584.51. 2,222,692 shares of the company traded hands, compared to its average volume of 4,165,217. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $591.54. The firm has a market capitalization of $539.75 billion, a price-to-earnings ratio of 35.59, a P/E/G ratio of 1.61 and a beta of 0.59. The business’s fifty day moving average is $536.09 and its 200 day moving average is $509.40.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same quarter last year, the company earned $6.14 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. Equities research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on UNH. Wells Fargo & Company lifted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Argus lifted their price target on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. Truist Financial raised their target price on UnitedHealth Group from $600.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Finally, Robert W. Baird upped their target price on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $614.17.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.